Healthcare 01 (Jul 08 - Apr 15)

[winston]

Health care boom sends medical device-maker Medtronic up 101% over the past three years, including dividends.

[winston]

A bullish sign for the health care uptrend… medical device-maker Becton-Dickinson surges to a new all-time high.

[winston]

Biotech boom keeps humming along… double-long fund BIB tops a short list of funds up 40%-plus over the past six months.

[winston]

Biotech has one of the best-looking uptrends in the entire market… sector funds XBI and IBB are up 20%-plus over the past six months.

[winston]

Biotech uptrend continues as sector fund IBB breaks out to a new all-time high.

[winston]

Booming drug market helps push "Big Pharma" fund PJP to a new all-time high.

[winston]

Booming drug market helps push "Big Pharma" fund PJP to a new all-time high.

[winston]

A HUGE UPTREND IN MEDICAL SERVICE STOCKS

"Picks and shovels" investing works... especially in the booming health care sector.

Over the years, we've helped thousands of readers learn why investing in "picks and shovels" is a great way to invest in sector booms. These businesses supply the vital tools, products, or services to many participants in a sector (to read our educational interview on "picks and shovels," go here).

As you likely know, the health care sector is booming. With millions of Baby Boomers reaching retirement age in the U.S. each year, health care demand is steadily growing. This trend has produced a solid uptrend in medical service stocks.

You can track (and invest in) the medical service industry with the SPDR S&P Health Care Services Fund (XHS). This fund owns a basket of companies that provide essential products and services ("picks and shovels") to America's hospitals, doctors' offices, and pharmacies.

As you can see, shares of XHS have doubled since late 2011... and they just set a new all-time high last week. It's boom time for the picks and shovels of the medical industry.

Source: Daily Wealth

[winston]

Worried about the market? Take a look at these stocks immediately by Dr. David Eifrig

There’s a lot of worry in the market right now.

People are worried about Europe going into recession. They’re worried about a Chinese slowdown.

But one area of the market is a sure bet to keep growing. It’s a sector that has made my readers a lot of money… and will continue to make them money for decades to come.

That sector is health care…

For years now, I’ve urged readers to buy health care stocks. The reasons are simple…

Aging Baby Boomers will keep health care demand high. Plus, Obamacare will create huge demand for all kinds of medical services. As I’ve said before, I’m not a fan of Obamacare… but I know the resulting health care boom means we have to be invested in health care for the long term.

Put simply, the market expected business to pick up as Obamacare added newly insured customers to the system. And that’s exactly what happened. About 7 million people have registered for insurance under the new health care regime, and another 2 million are expected to join next year.

That has driven health care stocks ahead of the market. Take a look:

For instance, one of my favorite medical stocks, which I’ve mentioned here before, is Medtronic (MDT). I first recommended Medtronic in Retirement Millionaire in February 2011. Since then, it’s up more than 80%. And I expect that number to continue to grow…

Medtronic is the world’s largest medical-device company. It makes cutting-edge medical devices like pacemakers, heart valves, and surgical technologies. Medtronic has raised its dividend for 37 years in a row. Rising health care demand means rising profits and more share-price gains for Medtronic.

Medtronic and other blue-chip health care companies all stand to grow from the expansion of Obamacare and the aging of Baby Boomers. They’ve outperformed the broad market for several years now… and I expect the outperformance to continue.

If you don’t have a healthy exposure to the sector in your portfolio, you should buy health care stocks today.

Source: Retirement Milionaire

[winston]

China

Deutsche: Pharmaceutical sector stabilizes in 3Q; SIHUAN PHARM, PHOENIXHEALTH chosen as Top Picks

Deutsche Bank stated that the drug sector was in face of continuous growth deceleration in July and August but a significant recovery in September, as revealed by the hospital data in the Mainland. The broker stressed that the growth in September was not due to the low base.

The growth stabilized at 12% in the third quarter, with healthy growth in the majority of flagship products.

SIHUAN PHARM (00460.HK) -0.040 (-0.681%) Short selling $7.34M; Ratio 8.409% and PHOENIXHEALTH (01515.HK) +0.040 (+0.255%) Short selling $1.95M; Ratio 17.137% remained to be the top picks in drug sector.

Deutsche Bank maintained the Buy rating of Sihuan Pharmaceutical.

The target price of Phoenix Healthcare was lifted form $16 to $18, with a rating of Buy.

The target price of CMS (00867.HK) -0.040 (-0.285%) Short selling $4.47M; Ratio 5.535% was increased from $10.5 to $12 and the rating was maintained at Hold.

Source: AAStocks Financial News